These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 33666185)

  • 1. Regulatory approval for COVID-19 across the globe.
    Mahalmani V; Pugazhenthan T; Mittal N; Varthya SB; Medhi B
    Indian J Pharmacol; 2020; 52(6):457-466. PubMed ID: 33666185
    [No Abstract]   [Full Text] [Related]  

  • 2. The Challenges Ahead With Monoclonal Antibodies: From Authorization to Access.
    Goldstein RH; Walensky RP
    JAMA; 2020 Dec; 324(21):2151-2152. PubMed ID: 33175110
    [No Abstract]   [Full Text] [Related]  

  • 3. Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic.
    Watanabe JH; Kwon J; Nan B; Abeles SR; Jia S; Mehta SR
    JAMA Netw Open; 2021 May; 4(5):e2110775. PubMed ID: 34019090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Japan's Drug Regulation During the COVID-19 Pandemic: Lessons From a Case Study of Favipiravir.
    Ueda M; Tanimoto T; Murayama A; Ozaki A; Kami M
    Clin Pharmacol Ther; 2022 Mar; 111(3):545-547. PubMed ID: 33882157
    [No Abstract]   [Full Text] [Related]  

  • 5. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
    Ison MG; Wolfe C; Boucher HW
    JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438
    [No Abstract]   [Full Text] [Related]  

  • 6. 'A very, very bad look' for remdesivir.
    Cohen J; Kupferschmidt K
    Science; 2020 Nov; 370(6517):642-643. PubMed ID: 33154114
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA Approval of Remdesivir - A Step in the Right Direction.
    Rubin D; Chan-Tack K; Farley J; Sherwat A
    N Engl J Med; 2020 Dec; 383(27):2598-2600. PubMed ID: 33264539
    [No Abstract]   [Full Text] [Related]  

  • 8. A Proposed Lottery System to Allocate Scarce COVID-19 Medications: Promoting Fairness and Generating Knowledge.
    White DB; Angus DC
    JAMA; 2020 Jul; 324(4):329-330. PubMed ID: 32579158
    [No Abstract]   [Full Text] [Related]  

  • 9. Remdesivir Approved to Treat COVID-19 Amid Controversy.
    Aschenbrenner DS
    Am J Nurs; 2021 Jan; 121(1):22-24. PubMed ID: 33350691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Remdesivir in Myasthenia gravis and COVID-19.
    Peters BJ; Rabinstein AA; DuBrock HM
    Pharmacotherapy; 2021 Jun; 41(6):546-550. PubMed ID: 33835512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study.
    Mehta HB; An H; Andersen KM; Mansour O; Madhira V; Rashidi ES; Bates B; Setoguchi S; Joseph C; Kocis PT; Moffitt R; Bennett TD; Chute CG; Garibaldi BT; Alexander GC;
    Ann Intern Med; 2021 Oct; 174(10):1395-1403. PubMed ID: 34399060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experts Discuss COVID-19-Remdesivir, Vaccines, and More.
    JAMA; 2020 Aug; 324(8):730-731. PubMed ID: 32777002
    [No Abstract]   [Full Text] [Related]  

  • 13. Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19.
    Anton-Vazquez V; Clivillé R
    Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1353-1355. PubMed ID: 33462723
    [No Abstract]   [Full Text] [Related]  

  • 14. Missed Opportunities on Emergency Remdesivir Use.
    Sarpatwari A; Kaltenboeck A; Kesselheim AS
    JAMA; 2020 Jul; 324(4):331-332. PubMed ID: 32579163
    [No Abstract]   [Full Text] [Related]  

  • 15. What Do We Know About Remdesivir Drug Interactions?
    Yang K
    Clin Transl Sci; 2020 Sep; 13(5):842-844. PubMed ID: 32402130
    [No Abstract]   [Full Text] [Related]  

  • 16. Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Nov; 383(19):e123. PubMed ID: 33211936
    [No Abstract]   [Full Text] [Related]  

  • 17. Audio Interview: A Potential New Agent to Treat Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Dec; 385(26):e101. PubMed ID: 34936745
    [No Abstract]   [Full Text] [Related]  

  • 18. A Potential Antiviral Treatment for COVID-19: Remdesivir.
    O'Malley PA
    Clin Nurse Spec; 2020; 34(6):257-260. PubMed ID: 33009111
    [No Abstract]   [Full Text] [Related]  

  • 19. Research shows racial disparity, mortality data for patients with cancer and COVID-19.
    Printz C
    Cancer; 2021 Feb; 127(3):333. PubMed ID: 33434336
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review.
    Cantini F; Goletti D; Petrone L; Najafi Fard S; Niccoli L; Foti R
    Drugs; 2020 Dec; 80(18):1929-1946. PubMed ID: 33068263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.